MEDIA RELEASE
Date: 27 February 2017
MOMENTUM CONTINUES TO BUILD AT METLIFECARE WITH RECORD INTERIM RESULT
Metlifecare Limited performance highlights for the six months to 31 December 2016[1] :
• Reported
net profit after tax of $165.0 million, up
31%
• Underlying profit[2] of $38.6 million, up
15%
• Total assets of $2,805.9 million, up
15%
• $70.0 million invested into villages, up
22%
• Development margin[3] up from 12% to 17%
• 97 new
units delivered as scheduled, up 26%
• Net tangible
assets per share of $6.04, up 25%
• Interim dividend of
2.25 cents per share, up 29%
• Second half underlying
profit anticipated to be consistent with the first
half
Metlifecare today announced a record half-year result for the six months to 31 December 2016. Reported net profit after tax grew by 31% to $165.0 million, driven by continued gains in the fair value of its assets, and a solid operating performance.
The company’s underlying profit, which removes non-cash items, was $38.6 million, 15% higher than the same period last year. Total asset values increased by 15% to $2,805.9 million, and earnings per share were 77.1 cents, 30% higher than last year.
Metlifecare’s Chief Executive Officer Glen Sowry said it was a pleasing performance. “We have continued to experience strong sales price growth and market conditions in our stronghold regions of Auckland and the Bay of Plenty. We are on track to meet our 2017 development delivery targets and, looking further out, have also made excellent progress on a number of strategic initiatives that will drive accelerated growth and create a competitive edge in the markets we are targeting.”
“We expect to achieve our delivery target of 229 units and care beds in this financial year, and are also well on track to deliver a further 233 units and beds in the 2018 financial year. Our development margin of 17% for the period was well ahead of last year’s 12%.”
Mr
Sowry said reduced stock availability led to lower sales
volumes of new units during the period with 89 new units
sold, down 14% against the previous corresponding period.
“However the impact of this was offset by an average price
increase of 9% to $638,000 per unit, which combined with the
increased development margin to drive a realised development
margin of $9.6 million, 35% higher than last
year.”
Village occupancy increased to 97% compared to
96% in the same period last year, and care home occupancy is
tracking above the national average. Unit resales volumes
were 13% down on last year at 175 units, partly because 17
units at Pinesong village were unavailable for resale.
These units were used by the company to rehouse residents of
the Manukau building which is being replaced with a new
apartment block. The average resale price increased by 16%
to $489,000 per unit, driven by a combination of increased
sales prices and the mix of units sold, and the realised
resale gain per settlement increased by 36% to $151,000.
Overall, net operating cash flow for the six-month period
was $79.0 million, 1% higher than last year.
Embedded value[4] is calculated by Metlifecare as a key indicator of future cash flow generated when a unit is reoccupied. Embedded value for the half-year period increased to $251,000 per unit, 40% ahead of last year, reflecting the continued house price growth and resale prices achieved.
Metlifecare delivered 97 new units during the period under review, with a further 288 units and beds under construction at 31 December 2016. The current development land bank includes a further 1,647 units and beds for delivery in subsequent years. There were no further land acquisitions made during the period, despite detailed reviews being conducted on a number of potential sites.
“We are taking a prudent and methodical approach to ensuring any new site is aligned with Metlifecare’s vision for its future villages and meets our investment criteria, which include demographics, median market pricing, home ownership levels and growth rates. Whilst we are hopeful to sign and settle a land acquisition this calendar year, we will continue to be careful that any such acquisition is value-accretive and targeted,” said Mr Sowry.
Mr Sowry said the company’s strong balance sheet kept it well-positioned to capture future investment opportunities and lift development activity, while at the same time providing a buffer in the event of softening market conditions. “We invested $70.0 million into our villages during the six-month period. Bank debt reduced to $76.1 million from $80.8 million, and Metlifecare’s debt to equity ratio reduced from 7% to 6% over the period.”
Operations
Operationally,
Mr Sowry said momentum was building across the business with
a number of new initiatives implemented during the period.
“Many of these programmes have a long-term focus, and we
will not achieve the full benefits overnight. However, I am
pleased to report demonstrable progress is already being
made.”
“We have seen a noticeable lift in the quality and efficiency of unit refurbishment, with lower turnaround times and an increased average resale gain per unit. These improvements represent a win-win for the families of residents as well as Metlifecare.”
“We are continually seeking to lift our market positioning and competitiveness by improving the village experience for our residents. We were delighted to recently announce a partnership with Simon Gault in which he will work with our own qualified village chefs to enhance the village dining experience. This initiative is in response to resident feedback which has reinforced the importance of food in bringing families together.”
Mr Sowry said Metlifecare would also continue to invest in maintaining the competitiveness and amenity value of its villages. “We are expanding our long-term maintenance plan into a 10-year village regeneration programme, and are well advanced in a company-wide review to assess what is required. By the end of 2017 all villages will have a 10-year plan in place which focuses on ensuring that they remain competitive and able to meet the future demands and expectations of residents.”
“In terms of remediation, a comprehensive review has also been completed of all at-risk villages, and we have accordingly increased the estimate of future remediation costs by $23.5 million in the financial statements. This is in addition to the $20.6 million estimated at 30 June 2016 (excludes earthquake works of $1.4 million) and will occur over a period of seven years.”
“Our broader village regeneration programme already has a number of initiatives under way. These include the replacement of a 19-unit apartment block with a modern 48-unit block at Pinesong in Titirangi; and the recent announcement of a planned village-wide regeneration at Pakuranga Village, including the replacement of the aging care home with a new state-of-the-art facility, which will capture latent value. We are pleased with the progress being made in this area, as asset optimisation and protection are critical to our long-term sustainability and profitability,” said Mr Sowry.
Dividend
The Board has declared
an interim dividend of 2.25 cents per share for the
six-month period ended 31 December 2016, 29% higher than
last year. The dividend is un-imputed and will be paid on 31
March 2017, with a record date of 17 March 2017.
Chief Financial Officer
The company
also advises that after more than six years in his role as
Chief Financial Officer, Tristram van der Meijden has made
the decision to leave Metlifecare at the end of September
this year to focus on his personal business interests.
Mr Sowry acknowledged Mr van der Meijden’s contribution, “Tristram has made a significant and valuable contribution to Metlifecare over his tenure providing leadership through the GFC, the recapitalisation of the company and the merger in 2012, and will leave the organisation in a strong position. An executive search process is now underway and we will work towards a smooth transition later this year.”
Summary and
Outlook
Metlifecare’s Chair Kim Ellis said the
Board was pleased with the company’s performance over the
half year. “Metlifecare has made solid progress. It has
established and communicated its strategic goals and
delivery targets, and there is renewed focus across the
business. This has contributed towards another record
result despite lower sales volumes, which is very
satisfying.”
Looking ahead, Mr Sowry said demand for Metlifecare’s villages remained strong and the company was seeing the benefits of increased commercial intensity through improved yields and higher occupancy levels. The company anticipates that underlying profit for the second half will be consistent with the first half.
“We will continue to invest in our existing village portfolio as well as seeking growth opportunities that align with our strategic goals. Overall, the company remains well-positioned to meet the opportunities and challenges of our sector, and we have a robust platform from which we can evolve and expand our offering in a changing and competitive market place.”
ENDS
[1] Comparison is
with the 6 months to 31 December 2015.
[2]
Underlying profit removes the impact of unrealised fair
value movements on investment properties, impairment of
property, plant & equipment and excludes one-off gains &
losses and taxation, and is reconciled to reported profit in
the performance summary attached to this announcement. It is
a non-GAAP financial measure and is not prepared in
accordance with NZ IFRS. Refer note 2.2 of the Interim
Financial Statements for additional detail. Underlying
profit is provided as an industry-wide measure to assist
readers.
[3] Refer note 2.2 of the Interim
Financial Statements for additional detail.
[4]
Embedded value is a non-GAAP financial measure and is not
prepared in accordance with NZ IFRS. It is calculated by
taking the sum of the CBRE unit prices of units across the
portfolio, deducting the resident refundable loan liability
as per the balance sheet and company-owned stock items.
Embedded value is provided to assist
readers.
To view documents released to the market in connection with the Half Year Result to 31 December 2016 please click on the links below:
1. Media Release
2. NZX Appendix 1 Information
3. Unaudited Interim Financial Statements - 31
December 2016
4. Results Presentation
5. NZX Appendix 7 Information